tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Tang S and Lai KN Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft. 2005 Am. J. Kidney Dis. pmid:15806458
Rao PS Nephrotic syndrome in patients with peripheral blood stem cell transplant. 2005 Am. J. Kidney Dis. pmid:15806483
de Mattos AM et al. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. 2000 Am. J. Kidney Dis. pmid:10676738
Kooman JP et al. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. 2001 Am. J. Kidney Dis. pmid:11382685
Choudhry S et al. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. 2009 Am. J. Kidney Dis. pmid:19268410
Haas M et al. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. 1999 Am. J. Kidney Dis. pmid:10401019
Wong TY et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. 1999 Am. J. Kidney Dis. pmid:10585325
Hricik DE Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583939
Pescovitz MD and Govani M Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583940
Tang S et al. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome. 2003 Am. J. Kidney Dis. pmid:14582073
Pham PT et al. Cyclosporine and tacrolimus-associated thrombotic microangiopathy. 2000 Am. J. Kidney Dis. pmid:11007689
Revelo MP et al. A 14-year-old boy with kidney allograft failure in the first month after transplantation. 2000 Am. J. Kidney Dis. pmid:11007695
Lien YH and Bracamonte ER Quiz page February 2011: acute kidney injury, graft pain, and subtherapeutic levels of tacrolimus. 2011 Am. J. Kidney Dis. pmid:21251536
Pavan M et al. Altered bioavailability of tacrolimus following intravenous administration of tigecycline. 2011 Am. J. Kidney Dis. pmid:21251548
Vischini G et al. Increased plasma levels of tacrolimus after ingestion of green tea. 2011 Am. J. Kidney Dis. pmid:21787983
Moes AD et al. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. 2017 Am. J. Kidney Dis. pmid:28259499
Wong KM et al. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. 2000 Am. J. Kidney Dis. pmid:10739787
Böhmig GA et al. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. 2000 Am. J. Kidney Dis. pmid:10739788
Starzl TE et al. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. 1998 Am. J. Kidney Dis. pmid:9631858
Li X et al. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. 2009 Am. J. Kidney Dis. pmid:19406543
Al-Awwa IA et al. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. 1998 Am. J. Kidney Dis. pmid:9631859
Lum EL et al. Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma. 2017 Am. J. Kidney Dis. pmid:28189378
Neylan JF et al. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine. 1998 Am. J. Kidney Dis. pmid:9820446
Chen W et al. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial. 2011 Am. J. Kidney Dis. pmid:21177013
Mertz D et al. Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus. 2009 Am. J. Kidney Dis. pmid:19346040
Israni A et al. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. 2002 Am. J. Kidney Dis. pmid:11877596
Soi V et al. Altered mental status in a kidney transplant recipient receiving tacrolimus. 2008 Am. J. Kidney Dis. pmid:18155524
Reese PP et al. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. 2017 Am. J. Kidney Dis. pmid:27940063
Mathis AS and Friedman GS Coadministration of digoxin with itraconazole in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11157404
Tsinalis D et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. 2002 Am. J. Kidney Dis. pmid:12200824
Asif A et al. Peritoneoscopic placement of peritoneal dialysis catheter and bowel perforation: experience of an interventional nephrology program. 2003 Am. J. Kidney Dis. pmid:14655200
Grinyó JM et al. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. 2017 Am. J. Kidney Dis. pmid:27889299
Lien YH Top 10 Things Primary Care Physicians Should Know About Maintenance Immunosuppression for Transplant Recipients. 2016 Am. J. Med. pmid:26714210
Bar J et al. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. 2003 Am. J. Med. Genet. A pmid:12476448
Perez-Aytes A et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? 2008 Am. J. Med. Genet. A pmid:18074358
Chen W et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial. 2013 Am. J. Med. Sci. pmid:22627258
Hsu MS et al. Clinical features and outcome of tuberculosis in solid organ transplant recipients. 2007 Am. J. Med. Sci. pmid:17700199
Ocampo-Garza J et al. Acquired Hyperpigmentation and Cicatricial Alopecia. 2016 Am. J. Med. Sci. pmid:27524226
Chen M et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. 2010 Am. J. Med. Sci. pmid:20220333
Esposito C et al. Sirolimus prevents short-term renal changes induced by ischemia-reperfusion injury in rats. 2011 Am. J. Nephrol. pmid:21358177
Ren H et al. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. 2013 Am. J. Nephrol. pmid:23343906
Araujo LP et al. Interaction of the anti-inflammatory annexin A1 protein and tacrolimus immunosuppressant in the renal function of rats. 2010 Am. J. Nephrol. pmid:20484890
Fourtounas C et al. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients. 2010 Am. J. Nephrol. pmid:20484893
Bhimma R et al. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. 2006 Am. J. Nephrol. pmid:17159342
Tsipotis E et al. Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis. 2016 Am. J. Nephrol. pmid:27576318
Taber DJ et al. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24969370
Zhang Q et al. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy. 2012 Am. J. Nephrol. pmid:22456060
Dai DS et al. Protective Effect of Salvia Przewalskii Extract on Puromycin-Induced Podocyte Injury. 2015 Am. J. Nephrol. pmid:26439819
Jin J et al. Klotho Deficiency Aggravates Tacrolimus-Induced Renal Injury via the Phosphatidylinositol 3-Kinase-Akt-Forkhead Box Protein O Pathway. 2016 Am. J. Nephrol. pmid:27174564
Weir MR et al. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function. 2004 Jul-Aug Am. J. Nephrol. pmid:15237243